Parker, S.E
Arcturus Therapeutics (United States)
3 papers on CoChat
Most cited papers
- Verified
Self-replicating Semliki Forest virus RNA as recombinant vaccine
Zhou, X., Berglund, P., Rhodes, G., Parker, S. E., Jondal, M., & Liljeström, P. (1994) · Vaccine
Influenza Virus Research StudiesVirology and Viral Diseases
Cited by 193
- Verified
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 191
- Verified
Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus
Fleeton, M. N., Chen, M., Berglund, P., Rhodes, G., Parker, S. E., Murphy, M., Atkins, G. J., & Liljeström, P. (2001) · The Journal of Infectious Diseases
Influenza Virus Research StudiesImmunotherapy and Immune Responses
Cited by 157
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free